“Serendipitous” use of antimalarial drug may have improved outcome for a patient with ovarian cancer
A cancer patient with advanced ovarian cancer had a “remarkable” journey to recovery that may…
Browsing: ovarian cancer
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including…
Chemotherapy timing could influence how well the treatment works
Yanyan Yang, University of North Carolina – Chapel Hill and Aziz Sancar, University of North…
Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment…
ANZGOG 2018: Challenges in Precision Gynaecological Cancer in a Molecular Era
Review of the ANZGOG Annual Scientific Meeting 2018 The Annual Scientific Meeting (ASM) of the…
Personalised tumour vaccine shows promise in pilot trial
A new type of cancer vaccine has yielded promising results in an initial clinical trial…
Life-extending drug for ovarian cancer made available in Europe
Cancer patients in Europe can now receive a life-extending drug invented and developed by scientists…
Repurposing inhibitors may provide new treatment approach for ovarian cancer
Wistar researchers have found rationale for repurposing a class of antitumour compounds called HDAC inhibitors,…
Potential for personalised immunotherapy extended to large variety of cancers
A new study shows that ovarian cancer, which has proved resistant to currently available immunotherapies,…
AACR 2018: Chlamydia infection is associated with increased risk of ovarian cancer
An antibody that is present in the blood of women previously infected with the sexually…